Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Triple Negative Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05812807
What this trial is testing

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Early Stage Triple-Negative Breast CarcinomaAnatomic Stage IIIA Breast Cancer AJCC v8+1 more
Alliance for Clinical Trials in Oncology 1,295
Large-scale testing (Phase 3)Study completedNCT00022516
What this trial is testing

Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 1,086
Testing effectiveness (Phase 2)Looking for participantsNCT06245889
What this trial is testing

PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC

Who this might be right for
Triple Negative Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Large-scale testing (Phase 3)Study completedNCT03371017
What this trial is testing

The Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Neoplasms
Hoffmann-La Roche 595
Testing effectiveness (Phase 2)WithdrawnNCT02685306
What this trial is testing

Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast NeoplasmsTriple-Negative Breast Neoplasm+4 more
Peregrine Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT01194869
What this trial is testing

Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Emory University 25
Large-scale testing (Phase 3)Looking for participantsNCT06627712
What this trial is testing

SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC

Who this might be right for
TNBC - Triple-Negative Breast Cancer
West China Hospital 318
Not applicableLooking for participantsNCT06230185
What this trial is testing

CtDNA Based MRD Testing for NAC Monitoring in TNBC

Who this might be right for
TNBC - Triple-Negative Breast CancerMinimal Residual Disease
Personalis Inc. 422
Not applicableWithdrawnNCT07136493
What this trial is testing

Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+4 more
City of Hope Medical Center
Not applicableStudy completedNCT07820228
What this trial is testing

Survival Analysis of Early Triple Negative Breast Cancer (TNBC) Women Treated With Dose Dense Sequential Adjuvant Chemotherapy

Who this might be right for
Triple Negative Breast Cancer
Hellenic Cooperative Oncology Group 3,648
Early research (Phase 1)Active Not RecruitingNCT04427293
What this trial is testing

Preoperative Lenvatinib Plus Pembrolizumab in Early-Stage Triple-Negative Breast Cancer (TNBC)

Who this might be right for
Triple Negative Breast Cancer
University of Illinois at Chicago 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07011823
What this trial is testing

Immune-checkpoint Blockade After Partial Breast Irradiation by Pembrolizumab in Early TNBC

Who this might be right for
Triple-Negative Breast Neoplasm
Gangnam Severance Hospital 20
Not applicableLooking for participantsNCT07570524
What this trial is testing

Predicting Response to Immunochemotherapy in Early Triple Negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer (TNBC)
Center Eugene Marquis 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07610525
What this trial is testing

Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Trial

Who this might be right for
Triple Negative Breast CancerBlood and Image GuidedOptimization of Neoadjuvant Therapy+1 more
M.D. Anderson Cancer Center 200
Not applicableWithdrawnNCT06610097
What this trial is testing

TNBC Gut Microbiota During Neoadjuvant Treatment

Who this might be right for
Breast CancerTriple Negative Breast CancerEarly Stage Triple-Negative Breast Carcinoma
Scripps Health
Not applicableActive Not RecruitingNCT06876636
What this trial is testing

Zoledronic Acid Combined With EC-T for Triple-Negative Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Xijing Hospital 99
Testing effectiveness (Phase 2)Looking for participantsNCT06358573
What this trial is testing

Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK

Who this might be right for
Triple-negative Breast CancerTNBC - Triple-Negative Breast Cancer
Swiss Cancer Institute 61
Testing effectiveness (Phase 2)UnknownNCT03812393
What this trial is testing

Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast

Who this might be right for
Triple Negative Breast CancerEarly-stage Breast CancerHER2-positive Breast Cancer
West Cancer Center 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT05949021
What this trial is testing

OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer (TNBC)
Mridula George, MD 30
Large-scale testing (Phase 3)Looking for participantsNCT06966700
What this trial is testing

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Who this might be right for
Breast NeoplasmsTriple Negative Breast NeoplasmsHR Low-Positive/HER2-Negative Breast Neoplasms
Merck Sharp & Dohme LLC 2,400
Next Page